The proposed legislation, known as the Ensuring Reproductive Freedom by Shielding Our Providers Act, allows prescribers of certain pharmaceuticals, specifically mifepristone and misoprostol, to have the name of their health care practice displayed on prescription labels instead of their personal names. This change aims to enhance the privacy and safety of prescribers by protecting their identities, particularly in the context of reproductive health services. The bill defines key terms such as "dispenser," "pharmacy," and "prescriber," clarifying who is authorized to dispense these medications.

Under the new provisions, if a prescriber requests it, dispensers and pharmacies are required to comply by using the name of the prescriber's health care practice on the prescription label. This act is set to take effect 30 days after its passage.